Table 4. Coverage of eligible PSAC, SAC and adults across all three sampling sites with regards to PZQ and ALB.
| Drug | Age Group | Total | Treated | Coverage % (95% CI) | 
|---|---|---|---|---|
| PZQ | PSAC (0–4 yrs) | 278 | 203 | 73 (67.4–78.1) | 
| SAC (5–17 yrs) | 519 | 420 | 80.9 (77.3–84.2) | |
| Adults (18–75+ yrs) | 1474 | 974 | 66.1 (63.6–68.5) | |
| ALB | PSAC (0–4 yrs) | 403 | 312 | 77.4 (73–81.4) | 
| SAC (5–17 yrs) | 565 | 465 | 82.3 (78.9–85.4) | |
| Adults (18–75+ yrs) | 1284 | 901 | 70.2 (67.6–72.7) |